Compounds > carbamates

carbamates and n-formylmethionine leucyl-phenylalanine

carbamates has been researched along with n-formylmethionine leucyl-phenylalanine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Czartolomna, J; Murphy, RC; Simpson, J; Voelkel, NF1
Beblavy, MJ; Bridger, GJ; Derian, CK; Fischman, AJ; Higgins, JD; Kroon, DJ; Pike, MC; Santulli, RJ; Solomon, HF1
Fujii, K; Hamamura, I; Kishimoto, T; Mitsuhashi, H; Muratani, E; Nonaka, T1
Lucente, G; Nalli, M; Paradisi, MP; Spisani, S; Torrini, I; Zecchini, GP1
Arm, J; Borregaard, N; Degousee, N; Gelb, MH; Ghomashchi, F; Lambeau, G; Lichtenberger, C; Lindsay, TF; Reinisch, W; Reithmeier, R; Rubin, BB; Singer, A; Smart, BP; Stefanski, E; Tischfield, J1

Other Studies

5 other study(ies) available for carbamates and n-formylmethionine leucyl-phenylalanine

ArticleYear
FMLP causes eicosanoid-dependent vasoconstriction and edema in lungs from endotoxin-primed rats.
    The American review of respiratory disease, 1992, Volume: 145, Issue:3

    Topics: Alkaloids; Androstadienes; Animals; Carbamates; Dose-Response Relationship, Drug; Eicosanoids; Endotoxins; In Vitro Techniques; Male; N-Formylmethionine Leucyl-Phenylalanine; Phenylcarbamates; Phospholipase D; Protein Kinase C; Pulmonary Edema; Rats; Rats, Inbred Strains; Salmonella enteritidis; Staurosporine; Type C Phospholipases; Vasoconstriction; Wortmannin

1992
Selective inhibition of N-formylpeptide-induced neutrophil activation by carbamate-modified peptide analogues.
    Biochemistry, 1996, Jan-30, Volume: 35, Issue:4

    Topics: Adult; Amino Acid Sequence; Carbamates; Cell Adhesion; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Molecular Sequence Data; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Receptors, Formyl Peptide; Receptors, Immunologic; Receptors, Peptide; Structure-Activity Relationship; Superoxides

1996
Pharmacological activities of TEI-8362, a novel inhibitor of human neutrophil elastase.
    British journal of pharmacology, 1999, Volume: 126, Issue:5

    Topics: Animals; Butyrates; Butyric Acid; Carbamates; Cricetinae; Enzyme Inhibitors; Humans; Leukocyte Elastase; Lipopolysaccharides; Male; Mesocricetus; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Protective Agents; Respiratory Distress Syndrome; Substrate Specificity

1999
Biscarbamate analogues of the chemotactic tripeptide fMLF-OMe.
    Farmaco (Societa chimica italiana : 1989), 2000, Volume: 55, Issue:4

    Topics: Carbamates; Chemotactic Factors; Humans; Molecular Structure; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Peptides

2000
Groups IV, V, and X phospholipases A2s in human neutrophils: role in eicosanoid production and gram-negative bacterial phospholipid hydrolysis.
    The Journal of biological chemistry, 2002, Feb-15, Volume: 277, Issue:7

    Topics: Blotting, Western; Carbamates; Cell Separation; Cytosol; DNA, Complementary; Dose-Response Relationship, Drug; Eicosanoids; Enzyme Inhibitors; Escherichia coli; Flow Cytometry; Group IV Phospholipases A2; Group V Phospholipases A2; Group X Phospholipases A2; Humans; Hydrolysis; Indolizines; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phospholipases; Phospholipases A; Polymerase Chain Reaction; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transcription, Genetic

2002